Future Health
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Future Health
Asset Allocation
Position | Category/Sector | Weight |
---|---|---|
AstraZeneca PLC | Healthcare | 3.45% |
Eli Lilly and Company | Healthcare | 3.45% |
Neurocrine Biosciences, Inc. | Healthcare | 3.45% |
Boston Scientific Corporation | Healthcare | 3.45% |
Intuitive Surgical, Inc. | Healthcare | 3.45% |
Edwards Lifesciences Corporation | Healthcare | 3.45% |
Insulet Corporation | Healthcare | 3.45% |
Halozyme Therapeutics, Inc. | Healthcare | 3.45% |
DexCom, Inc. | Healthcare | 3.45% |
Bristol-Myers Squibb Company | Healthcare | 3.45% |
Gilead Sciences, Inc. | Healthcare | 3.45% |
Biogen Inc. | Healthcare | 3.45% |
3.45% | ||
3.45% | ||
3.45% | ||
3.45% | ||
3.45% | ||
Alnylam Pharmaceuticals, Inc. | Healthcare | 3.45% |
3.45% | ||
BioMarin Pharmaceutical Inc. | Healthcare | 3.45% |
The Cooper Companies, Inc. | Healthcare | 3.45% |
IQVIA Holdings Inc. | Healthcare | 3.45% |
3.45% | ||
3.45% | ||
Ecolab Inc. | Basic Materials | 3.45% |
Agilent Technologies, Inc. | Healthcare | 3.45% |
Medtronic plc | Healthcare | 3.45% |
3.45% | ||
Merck & Co., Inc. | Healthcare | 3.45% |
Quarterly